Drug Profile
Recilisib - Traws Pharma
Alternative Names: Ex-RAD; ON 01210.Na; ON-01210; ON-01210-Na; Recilisib sodiumLatest Information Update: 04 Apr 2024
Price :
$50
*
At a glance
- Originator Onconova Therapeutics
- Developer Traws Pharma
- Class Radioprotectives; Small molecules; Sulfonamides
- Mechanism of Action Apoptosis inhibitors; Protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Acute radiation syndrome